🚀 VC round data is live in beta, check it out!
Labo Euromedis Valuation Multiples
Discover revenue and EBITDA valuation multiples for Labo Euromedis and similar public comparables like Modular Medical, Vicarious Surgical, Allurion, Scandinavian Medical and more.
Labo Euromedis Overview
About Labo Euromedis
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
Founded
1996
HQ
Employees
21
Website
Financials (LTM)
EV
$6M
Labo Euromedis Financials
Labo Euromedis reported last 12-month revenue of $45M and EBITDA of $2M.
In the same LTM period, Labo Euromedis generated $2M in EBITDA and $2M in net income.
Revenue (LTM)
Labo Euromedis P&L
In the most recent fiscal year, Labo Euromedis reported revenue of $42M and EBITDA of $1M.
Labo Euromedis expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $45M | XXX | $42M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBITDA | $2M | XXX | $1M | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 2% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $2M | XXX | ($7M) | XXX | XXX | XXX |
| Net Margin | 4% | XXX | (17%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Labo Euromedis Stock Performance
Labo Euromedis has current market cap of $15M, and enterprise value of $6M.
Market Cap Evolution
Labo Euromedis' stock price is $5.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6M | $15M | (0.2%) | XXX | XXX | XXX | $-2.49 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLabo Euromedis Valuation Multiples
Labo Euromedis trades at 0.1x EV/Revenue multiple, and 3.1x EV/EBITDA.
EV / Revenue (LTM)
Labo Euromedis Financial Valuation Multiples
As of March 7, 2026, Labo Euromedis has market cap of $15M and EV of $6M.
Equity research analysts estimate Labo Euromedis' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Labo Euromedis has a P/E ratio of 8.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $15M | XXX | $15M | XXX | XXX | XXX |
| EV (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 3.1x | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBIT | 4.5x | XXX | 4.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.9x | XXX | XXX | XXX |
| P/E | 8.3x | XXX | (2.1x) | XXX | XXX | XXX |
| EV/FCF | 4.2x | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Labo Euromedis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Labo Euromedis Margins & Growth Rates
Labo Euromedis' revenue in the last 12 month grew by 3%.
Labo Euromedis' revenue per employee in the last FY averaged $2.1M.
Labo Euromedis' rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Labo Euromedis' rule of X is 11% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Labo Euromedis Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 100% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 7% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 11% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $2.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 2% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Labo Euromedis Public Comps
See public comps and valuation multiples for other Medical Devices and Wholesale Distribution comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Modular Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Vicarious Surgical | XXX | XXX | XXX | XXX | XXX | XXX |
| Allurion | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Polyrizon | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Labo Euromedis M&A Activity
Labo Euromedis acquired XXX companies to date.
Last acquisition by Labo Euromedis was on XXXXXXXX, XXXXX. Labo Euromedis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Labo Euromedis
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLabo Euromedis Investment Activity
Labo Euromedis invested in XXX companies to date.
Labo Euromedis made its latest investment on XXXXXXXX, XXXXX. Labo Euromedis invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Labo Euromedis
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Labo Euromedis
| When was Labo Euromedis founded? | Labo Euromedis was founded in 1996. |
| Where is Labo Euromedis headquartered? | Labo Euromedis is headquartered in France. |
| How many employees does Labo Euromedis have? | As of today, Labo Euromedis has over 21 employees. |
| Is Labo Euromedis publicly listed? | Yes, Labo Euromedis is a public company listed on Euronext Paris. |
| What is the stock symbol of Labo Euromedis? | Labo Euromedis trades under ALEMG ticker. |
| When did Labo Euromedis go public? | Labo Euromedis went public in 2000. |
| Who are competitors of Labo Euromedis? | Labo Euromedis main competitors are Modular Medical, Vicarious Surgical, Allurion, Scandinavian Medical. |
| What is the current market cap of Labo Euromedis? | Labo Euromedis' current market cap is $15M. |
| What is the current revenue of Labo Euromedis? | Labo Euromedis' last 12 months revenue is $45M. |
| What is the current revenue growth of Labo Euromedis? | Labo Euromedis revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Labo Euromedis? | Current revenue multiple of Labo Euromedis is 0.1x. |
| Is Labo Euromedis profitable? | Yes, Labo Euromedis is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Labo Euromedis? | Labo Euromedis' last 12 months EBITDA is $2M. |
| What is Labo Euromedis' EBITDA margin? | Labo Euromedis' last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of Labo Euromedis? | Current EBITDA multiple of Labo Euromedis is 3.1x. |
| What is the current FCF of Labo Euromedis? | Labo Euromedis' last 12 months FCF is $2M. |
| What is Labo Euromedis' FCF margin? | Labo Euromedis' last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Labo Euromedis? | Current FCF multiple of Labo Euromedis is 4.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.